These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10699434)
1. Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. Wu YY; Hruszkewycz AM; Delgado RM; Yang A; Vortmeyer AO; Moon YW; Weil RJ; Zhuang Z; Remaley AT Clin Chim Acta; 2000 Mar; 293(1-2):199-212. PubMed ID: 10699434 [TBL] [Abstract][Full Text] [Related]
2. [Detection of human telomerase activity by telomerase TRAP-ELISA assay]. Wei L; Guo Y; Yan Z Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):264-6. PubMed ID: 10920979 [TBL] [Abstract][Full Text] [Related]
3. SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Wege H; Chui MS; Le HT; Tran JM; Zern MA Nucleic Acids Res; 2003 Jan; 31(2):E3-3. PubMed ID: 12527792 [TBL] [Abstract][Full Text] [Related]
4. High-throughput analysis of telomerase by capillary electrophoresis. Atha DH; Miller K; Sanow AD; Xu J; Hess JL; Wu OC; Wang W; Srivastava S; Highsmith WE Electrophoresis; 2003 Jan; 24(1-2):109-14. PubMed ID: 12652580 [TBL] [Abstract][Full Text] [Related]
5. A quantitative method to measure telomerase activity by bioluminescence connected with telomeric repeat amplification protocol. Xu S; He M; Yu H; Cai X; Tan X; Lu B; Shu B Anal Biochem; 2001 Dec; 299(2):188-93. PubMed ID: 11730342 [TBL] [Abstract][Full Text] [Related]
6. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Hou M; Xu D; Björkholm M; Gruber A Clin Chem; 2001 Mar; 47(3):519-24. PubMed ID: 11238306 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of bladder cancer using telomerase activity in voided urine. Cheng CW; Chueh SC; Chern HD J Formos Med Assoc; 2000 Dec; 99(12):920-5. PubMed ID: 11155745 [TBL] [Abstract][Full Text] [Related]
8. Modified telomeric repeat amplification protocol: a quantitative radioactive assay for telomerase without using electrophoresis. Szatmari I; Tókés S; Dunn CB; Bardos TJ; Aradi J Anal Biochem; 2000 Jun; 282(1):80-8. PubMed ID: 10860502 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848 [TBL] [Abstract][Full Text] [Related]
10. Real-time telomeric repeat amplification protocol using the duplex scorpion and two reverse primers system: the high sensitive and accurate method for quantification of telomerase activity. Huang YP; Liu ZS; Tang H; Liu M; Li X Clin Chim Acta; 2006 Oct; 372(1-2):112-9. PubMed ID: 16714009 [TBL] [Abstract][Full Text] [Related]
11. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients. Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of PCR-ELISA for determination of telomerase activity in prostate needle biopsy and prostatic fluid specimens. Wang Z; Ramin SA; Tsai C; Lui P; Ruckle HC; Beltz RE; Sands JF; Slattery CW Urol Oncol; 2002; 7(5):199-205. PubMed ID: 12644217 [TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Yoshida K; Sugino T; Tahara H; Woodman A; Bolodeoku J; Nargund V; Fellows G; Goodison S; Tahara E; Tarin D Cancer; 1997 Jan; 79(2):362-9. PubMed ID: 9010110 [TBL] [Abstract][Full Text] [Related]
14. A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia. Ohyashiki K; Yahata N; Ohyashiki JH; Iwama H; Hayashi S; Ando K; Aizawa T; Ito T; Miki M; Ebihara Y Cancer; 1998 Dec; 83(12):2554-60. PubMed ID: 9874463 [TBL] [Abstract][Full Text] [Related]
15. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]. Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058 [TBL] [Abstract][Full Text] [Related]
16. [Telomerase activity and determination of cancer in urological neoplasias using exfoliated urinary cells: in situ TRAP assay and its application]. Ohyashiki K; Yahata N; Iwama H; Aizawa T; Miki M Nihon Rinsho; 1998 May; 56(5):1299-303. PubMed ID: 9613141 [TBL] [Abstract][Full Text] [Related]
17. Nonradioactive detection of telomerase activity using a PCR-ELISA-based telomeric repeat amplification protocol. Emrich T; Karl G Methods Mol Biol; 2002; 191():147-58. PubMed ID: 11951603 [No Abstract] [Full Text] [Related]
18. Microarray TRAP--a high-throughput assay to quantitate telomerase activity. Heller-Uszynska K; Kilian A Biochem Biophys Res Commun; 2004 Oct; 323(2):465-72. PubMed ID: 15369774 [TBL] [Abstract][Full Text] [Related]
19. Bioluminescent method for detecting telomerase activity. Xu SQ; He M; Yu HP; Wang XY; Tan XL; Lu B; Sun X; Zhou YK; Yao QF; Xu YJ; Zhang ZR Clin Chem; 2002 Jul; 48(7):1016-20. PubMed ID: 12089169 [TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in malignant and benign bladder conditions. Mayfield MP; Shah T; Flannigan GM; Hamilton Stewart PA; Bibby MC Int J Mol Med; 1998 May; 1(5):835-40. PubMed ID: 9852304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]